Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Varian Names Chief Medical Officer for Interventional Oncology | ||
By: PR Newswire Association LLC. - 16 Sep 2019 | Back to overview list |
|
PALO ALTO, Calif., Sept.16, 2019 /PRNewswire/ -- Varian (NYSE: VAR) has named Francis R. Facchini, M.D., FSIR, as the new chief medical officer, Interventional Oncology, reporting to Dee Khuntia, Varian chief medical officer. Effective September 3, 2019, Dr. Facchini has global responsibility for overseeing all aspects of this area including ongoing development of Varian's innovative IO treatment offerings, clinical strategy, and helping advance the field of interventional oncology as an important pillar of patient care. Dr. Facchini was most recently chief medical officer and head of medical affairs for BTG Plc. where he had responsibility for developing and commercializing products targeting critical care, cancer, vascular and other disorders. Facchini previously had served as global director of Medical and Clinical Affairs for Angiodynamics, Inc. and was chief medical officer of Navilyst Medical, Inc. "Frank will be a great addition to the Varian Medical Affairs team," said Khuntia. "He is a strategic thinker with strong business acumen and a deep understanding of this ever-changing industry. As a key opinion leader in the field of Interventional Oncology, Frank has a proven track record delivering highly creative, impactful solutions that will benefit Varian in our fight against cancer." "Varian is known for keeping patients at the center of its thinking and developing the most advanced technologies to fight cancer," said Facchini. "Varian excels at bringing together the greatest scientists, clinicians and researchers to do great things to advance oncology treatment. This is the most ideal time in my career path to be joining this team." Among his many academic achievements, Dr. Facchini received a Doctor of Medicine from Loyola University, Stritch School of Medicine and a BA in Philosophy from DePauw University. About Varian Press Contact Mark Plungy Investor Relations Contact J. Michael Bruff
View original content:http://www.prnewswire.com/news-releases/varian-names-chief-medical-officer-for-interventional-oncology-300918045.html SOURCE Varian |
||
|
||
Copyright 2019 PR Newswire Association LLC. | Back to overview list |